---
title: "中國飛鶴斥 3 億人民幣認購信行金融產品"
description: "中國飛鶴公佈，12 月 18 日，全資附屬黑龍江飛鶴以閒置資金認購中信銀行發售的金額 3 億人民幣金融產品。至今，集團向中信銀行認購之理財及結構性存款金融產品未到期本金金額共計 25 億人民幣。"
type: "news"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/270402842.md"
published_at: "2025-12-21T11:16:40.000Z"
---

# 中國飛鶴斥 3 億人民幣認購信行金融產品

> 中國飛鶴公佈，12 月 18 日，全資附屬黑龍江飛鶴以閒置資金認購中信銀行發售的金額 3 億人民幣金融產品。至今，集團向中信銀行認購之理財及結構性存款金融產品未到期本金金額共計 25 億人民幣。

中國飛鶴 (06186.HK) 公佈，12 月 18 日，全資附屬黑龍江飛鶴以閒置資金認購中信銀行發售的金額 3 億人民幣金融產品。至今，集團向中信銀行認購之理財及結構性存款金融產品未到期本金金額共計 25 億人民幣。

### Related Stocks

- [601998.CN - 中信銀行](https://longbridge.com/zh-HK/quote/601998.CN.md)
- [00998.HK - 中信銀行](https://longbridge.com/zh-HK/quote/00998.HK.md)
- [06186.HK - 中國飛鶴](https://longbridge.com/zh-HK/quote/06186.HK.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| China Feihe Limited Invests RMB500 Million in SPD Bank Financial Products | China Feihe Limited (HK:6186) announced that its subsidiary, Feihe HLJ, has invested RMB500 million in financial product | [Link](https://longbridge.com/zh-HK/news/264403704.md) |
| China Feihe Says Unit Subscribes To CITIC Bank Products For RMB400 Mln | China Feihe Ltd :UNIT SUBSCRIBES TO CITIC BANK PRODUCTS FOR RMB400 MILLION | [Link](https://longbridge.com/zh-HK/news/258736270.md) |
| China Feihe Limited Enhances Capital Gains with Strategic Financial Product Subscription | China Feihe Limited (HK:6186) announced that its subsidiary, Feihe HLJ, has subscribed to financial products from SPD Ba | [Link](https://longbridge.com/zh-HK/news/262886154.md) |
| China Feihe's unit subscribed for certain financial products for RMB 200 million | China Feihe's unit subscribed for certain financial products for RMB 200 million | [Link](https://longbridge.com/zh-HK/news/262893064.md) |
| China Feihe Announces NL47 Procurement Framework Agreement with North Latitude 47 | China Feihe Limited announced a procurement framework agreement with Heilongjiang North Latitude 47 Green Organic Food C | [Link](https://longbridge.com/zh-HK/news/261085525.md) |

---

> **免責聲明**：本文內容僅供參考，不構成任何投資建議。